Insights on B2B outbound, AI-powered lead generation, and pipeline growth for manufacturers.
A reply is not a lead. Here is how manufacturers qualify cold outbound replies, classify intent signals, and hand off to sales inside 24 hours.
B2B data decays 2-3% per month. Here is how manufacturers research prospects at scale using firmographic, trade, and signal sources in 2026.
61% of B2B buyers now prefer rep-free buying. Here is the sequencing playbook for entering new export markets without hiring local sales reps.
73% of B2B buyers avoid suppliers that send irrelevant outreach. Here is what procurement managers actually want to see in a cold email in 2026.
Stop sending cold email from your main domain. Here is how to architect subdomains, allocate mailboxes per market, and plan daily volume in 2026.
A sequencing framework for manufacturers going from one export market to ten: 5-variable prioritization, multi-market architecture, and cadence.
Most manufacturers chase MQL volume and wonder why pipeline rots. The fix is not more leads. It is better-fit ones, scored against revenue, not raised hands.
Should you write to procurement managers in their language or in English? A region-by-region decision matrix based on 2025 proficiency data and real B2B buyer behavior.
67% of B2B buyers prefer rep-free purchasing, and procurement still opens roughly 30% of cold emails. The myth that procurement ignores outreach is wrong.
Cold email reply rates dropped from 8.5% in 2019 to 3-5% in 2026. Here is the new bar that separates professional B2B outbound from spam.
B2B buyers now rank their shortlist before they ever call a vendor. Here is what the 2025-2026 data says about how manufacturing sales actually works now.
Swiss antibody-drug conjugate CDMOs sit on a market projected to hit $15.4B in 2026. Here is how Cerbios, Lonza, ADC Therapeutics and Araris compete.
Sika alone booked CHF 8.58B in nine-month 2025 sales. Inside how Swiss adhesive and sealant makers reach EV, construction, and industrial buyers directly.
Foreign primes owe Swiss industry CHF 5.42 billion in offset work, yet SMEs won only 28% of it in 2025. How component suppliers reach those buyers.
Syngenta posted $13.7B in 2025 crop protection sales from Basel. How Swiss agrochemical manufacturers reach growers and formulators directly.
Swiss pharma exports hit CHF 118.4B in 2025. Inside the API and fine-chemicals manufacturers building global pipeline as Europe reshores production.
Leclanche secured a EUR 74.2M EU grant to scale Willstatt to 2 GWh. How Swiss battery cell makers can reach buyers as EU storage hits 27.1 GWh.
Swiss biologics CDMOs anchor a CHF 57.4B immunological export engine. How Lonza, Celonic and specialty players win clients beyond CPHI.
Medtronic Tolochenaz makes 1 in 4 pacemakers worldwide. Inside the Swiss cardiovascular device cluster and how SMEs reach hospital buyers.
Swiss firms lead the zirconia implant shift. The segment grows ~10% CAGR while titanium still holds 85%+. How makers reach metal-free dental buyers.